Literature DB >> 36105324

Novel 3-Aminopyrrolidine and Piperidine Macrocyclic Orexin Receptor Agonists for Treating Sleep Disorders.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2022        PMID： 36105324      PMCID： PMC9465892          DOI： 10.1021/acsmedchemlett.2c00341

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  6 in total

Review 1.  Sleep-Wake Neurochemistry.

Authors:  Sebastian C Holst; Hans-Peter Landolt
Journal:  Sleep Med Clin       Date:  2022-06

Review 2.  Sleep and anxiety: From mechanisms to interventions.

Authors:  Sarah L Chellappa; Daniel Aeschbach
Journal:  Sleep Med Rev       Date:  2021-12-08       Impact factor: 11.609

Review 3.  Orexin receptors: Targets and applications.

Authors:  Subhiksha Subramanian; Mirunalini Ravichandran
Journal:  Fundam Clin Pharmacol       Date:  2021-09-13       Impact factor: 2.748

Review 4.  Narcolepsy.

Authors:  Lucie Barateau; Fabio Pizza; Giuseppe Plazzi; Yves Dauvilliers
Journal:  J Sleep Res       Date:  2022-05-27       Impact factor: 5.296

Review 5.  The orexin story, sleep and sleep disturbances.

Authors:  Fabio Pizza; Lucie Barateau; Yves Dauvilliers; Giuseppe Plazzi
Journal:  J Sleep Res       Date:  2022-06-13       Impact factor: 5.296

Review 6.  The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis.

Authors:  Tao Xue; Xin Wu; Shujun Chen; Yanbo Yang; Zeya Yan; Zhaoming Song; Wei Zhang; Jianguo Zhang; Zhouqing Chen; Zhong Wang
Journal:  Sleep Med Rev       Date:  2021-11-26       Impact factor: 11.401
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.